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ABSTRACT
Objective: To evaluate gingival crevicular fluid (GCF) protein content and alkaline phosphatase
(ALP) activity in growing subjects in relation to stages of skeletal maturation, ie, the growth phase,
as prepubertal, pubertal, and postpubertal.
Subjects and Methods: Fifty healthy growing subjects (31 girls and 19 boys; age range, 7.8–
17.7 years) were enrolled in this study that followed a double-blind, prospective, cross-sectional
design. Collection of GCF was performed at the mesial and distal sites of both central incisors, for
the maxilla and mandible. Growth phase was assessed through the cervical vertebral maturation
method. GCF parameters were expressed as total protein content, total ALP activity, and
normalized ALP activity.
Results: The total GCF protein content was similar between the different growth phases. On the
contrary, the total ALP activity showed a peak for the pubertal growth phase. The normalized GCF
ALP activity was only poorly associated with growth phase. No differences were seen between the
maxillary and mandibular sites, or between the sexes, for any GCF parameter.
Conclusions: The total GCF protein content is not sensitive to the growth phase. However, GCF
ALP activity has potential as a diagnostic aid for identification of the pubertal growth phase
in individual subjects when expressed as total, but not normalized, values. (Angle Orthod.
0000;00:1–6.)
KEY WORDS: Gingival crevicular fluid; Protein content; Alkaline phosphatase; Growth phase;
Diagnosis; Orthodontics
INTRODUCTION
Identification of skeletal maturity, ie, the growth
phase, with particular regard to the onset of the
pubertal growth phase, has major clinical implications
when dealing with orthodontic treatment in growing
subjects, especially when there are skeletal disharmo-
nies.1,2 Several indices have been proposed to identify
the skeletal maturation phases, with the most common
being the radiography-based, hand-wrist analysis3 and
the cervical vertebral maturation (CVM) method.1
However, new possibilities might be provided by
biochemical markers, ie, biomarkers that avoid inva-
sive X-ray exposure and represent agents that are
directly involved in bone growth and remodeling.
Gingival crevicular fluid (GCF) is a potential source
of biomarkers, with molecular constituents that derive
mainly from serum, and also from the interstitial fluids
of periodontal tissues.4 Under healthy conditions, with
protein concentrations of the serum and tissues
constant, the total protein content of the GCF can be
considered as an index of the amount of GCF, its
volume. In particular, both the volume5 and total
protein content6 of the GCF have been used exten-
sively to calculate the concentrations of the different
GCF constituents, for their normalization. The total
protein content of the GCF has been used extensively,
as determination of the GCF volume is not fully reliable
due to evaporation.7
Of interest, GCF formation has been shown to be
correlated with serum steroid sex hormone changes
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during pubertal growth,8 and the total protein content of
the GCF has been reported to be greater in growing
subjects as compared with an older group.9 More
recently, total GCF alkaline phosphatase (ALP) activity
has been shown to be related to the pubertal growth
spurt and has thus been proposed as a noninvasive
diagnostic aid for the determination of optimal treat-
ment timing in functional jaw orthopedics.10 However,
no studies have investigated whether the total GCF
protein content is sensitive to the different growth
phases, nor which of the total or normalized GCF ALP
activities might be better suited as a biomarker for the
pubertal growth phase.
Therefore, the aim of the present prospective, double-
blind study was twofold: (1) evaluation of total GCF
protein content in relation to stages of individual growth
phase, as recorded through the CVM method,1 to
determine whether the total GCF protein content
represents a noninvasive biomarker of individual skeletal
maturation in growing orthodontic patients; and (2)
comparison of the sensitivities of the total and normalized
GCF ALP activities with respect to the growth phases.
MATERIALS AND METHODS
Study Population and Design
This study enrolled subjects who were seeking
orthodontic treatment and had never been treated
previously. Signed informed consent was obtained
from the parents of the subjects prior to entry into the
study, and the protocol was reviewed and approved by
the local ethical committee. The following enrollment
criteria were observed: (1) aged between 7 and
18 years; (2) intermediate or late mixed, or early
permanent phases of dentition; (3) good general health
with absence of any nutritional problems; (4) no use of
anti-inflammatory agents or antibiotics in the month
preceding entry to the study; (5) probing depth (PD)
not exceeding 4 mm for the whole dentition, and 3 mm
for the anterior sextants; and (6) full-mouth plaque
score and full-mouth bleeding score # 25%.
The subjects were scheduled for enrollment at their
first clinical examination; subsequently, during a second
visit 7 to 10 days prior to GCF collection, they
underwent a session of professional supragingival and
subgingival scaling and also received repeated oral
hygiene instructions. Moreover, between the profes-
sional scaling and the GCF collection, the subjects were
asked to rinse their mouths out twice a day with 0.012%
chlorhexidine mouthwash, and were not allowed to take
any anti-inflammatory agents or antibiotics. At the last
clinical session, when the GCF was collected for total
protein content and ALP activity determinations, their
clinical parameters were recorded, and lateral cephalo-
grams were recorded immediately after GCF collection.
A total of 54 consecutive subjects were screened, of
which 50 were enrolled in the study: 31 girls and 19
boys (mean age, 11.6 6 2.3 years; range, 7.8–
17.7 years). In particular, 28 of these subjects
constituted a subset of a different study.10
Clinical Assessment and GCF
Collection Procedures
Assessment of skeletal maturity was carried out
through the CVM method on lateral cephalograms.
This method comprises six stages (CS1 to CS6) for
cervical vertebral maturation.1 An experienced ortho-
dontist who was blinded to the GCF ALP activities
assessed the skeletal maturity of the subjects. Finally,
the subjects were clustered into three groups accord-
ing to their growth phases, as prepubertal (CS1 and
CS2), pubertal (CS3 and CS4), and postpubertal (CS5
and CS6).
The intraoral clinical examination was performed by
a single operator (Dr Perinetti) on four sites per each
maxillary and mandibular central incisor (mesial, distal,
medio-buccal, and medio-palatal/ lingual). The pres-
ence of supragingival plaque (PL+), gingival bleeding
within 15 seconds of probing (BOP+), and PD were
recorded as previously reported.11 GCF collection
was performed at two sites on each maxillary and
mandibular central incisor, as the mesial and distal
aspects, using #25 standardized sterile paper strips
(Inline, Torino, Italy), which were inserted 1 mm into
the gingival crevice and left in situ for 60 seconds.12
The four samples from the same dental arch, as either
maxillary or mandibular, were pooled and immediately
stored at 280uC, until analysis.
Biochemical Assays
The biochemical assays were performed by a single
blinded operator.
The four GCF samples from both the maxillary and
mandibular sites were resuspended in 250 mL buffer
containing 100 mM Tris and 1 mM MgCl2 (pH 9.8 6
0.1). The supernatant was recovered, and 180 mL was
used for the total enzymatic activity determination, with
50 mL used for total protein content determination.
The ALP activity was monitored by adding p-
nitrophenol phosphate to a final concentration of
6 mM, with a total sample volume of 200 mL. The
samples were incubated at 37uC for 120 minutes, and
the rate of increase in absorbance was read with an
ultraviolet-visible spectrophotometer, at 405 nm.10 For
each analysis, a control was used that consisted of the
reagent and the Tris buffer without any sample. By
using 18.45 as the p-nitrophenol mM absorptivity, the
absorbance was converted into enzyme activity units
(1 unit 5 1 mmol of p-nitrophenol released per minute
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at 37uC) and expressed as total activity, in mU per
sample.5
The total protein content was determined using the
bicinchoninic acid (BCA, Sigma-Aldrich Inc, St Louis,
Mo) and copper (II) sulphate pentahydrate (Sigma-
Aldrich) protein assay reagents, according to the
manufacturer instructions. Briefly, the BCA working
reagent was prepared by mixing 50 parts BCA reagent
with 1 part of copper (II) sulphate reagent, and mixing
until this was light green in color. Then, 160 mL BCA
working reagent was added to 40 mL of the remaining
samples after the enzymatic activity assay, and
incubated at 37uC for 60 minutes. Protein standard
curves were obtained against samples of bovine
serum albumin.
Finally, the normalized GCF ALP activity was
expressed as total activity divided by total protein
content (mU/mg proteins).
Data Analysis
The balancing of the experimental groups (clustered
as growth phases) by sex was tested by chi-square
analysis.
The following analyses were carried out considering
the maxillary and mandibular sites of each patient as
the statistical units. A Kruskal-Wallis test and a one-
way analysis of variance (ANOVA) were used to
assess the significances of the differences in the
number of PL+ and BOP+ sites and the mean PD,
respectively, among the different growth phases.
Between the maxillary and mandibular sites, within
each growth phase, the significances of the differences
of the percent PL+ and percent BOP+ were assessed
by Wilcoxon rank sum tests, while the significances of
the differences in the mean PD were assessed by
paired t-tests. The Kruskal-Wallis test, followed by a
Bonferroni-corrected Mann-Whitney U-test as for pair-
wise comparisons, were used to assess the signifi-
cances of the differences in total GCF protein content
and ALP activity (either total or normalized) among the
growth phases. Wilcoxon rank sum tests were used to
assess the significances of the differences between
the maxillary and mandibular sites, within each growth
phase, for all three of the GCF parameters.
The rest of the analyses were carried out by pooling
the maxillary and mandibular sites, thus considering
the subject as the statistical unit. For the three GCF
parameters, the effects size (ES) coefficients13 were
calculated as an index of potential diagnostic accuracy
in the identification of pubertal growth phase. The ES
coefficient of a given parameter is the ratio of the
difference between the recordings of two different
groups, ie, the prepubertal and pubertal groups,
divided by the within-group standard deviation (SD).
Here, a threshold of 1.0 was used to assess potential
good diagnostic accuracy in individual subjects.14
A P value less than .05 was used for rejection of the
null hypothesis.
RESULTS
The ages of the subjects clustered according to the
growth phases are shown in Table 1. The distribution
of the sexes was similar among the groups compared
(P . .9; not shown).
The pooled maxillary and mandibular percent PL+,
percent BOP+ as medians (25th; 75th percentiles)
were 12.5 (0; 21.9) and 6.3 (0; 12.5), respectively. The
mean 6 SD pooled maxillary and mandibular PD was
1.7 6 0.4 mm. No significant differences were seen
among the growth phases or between the maxillary
and mandibular sites within each growth phase (not
shown).
The GCF parameter scores are shown in Table 2.
Within each growth phase, no differences were seen
between the maxillary and mandibular sites for each of
the parameters. The maxillary and mandibular total
GCF protein contents showed no significant differenc-
es among the growth phases, although at the maxillary
sites the total GCF protein content was slightly greater
for the pubertal growth phase, as compared with the
prepubertal and postpubertal growth phases. The total
GCF ALP activity was significantly greater in the
pubertal growth phase as compared with the prepu-
bertal and postpubertal growth phases for both the
maxillary and mandibular sites. Moreover, lower total
GCF ALP activities were seen for the postpubertal
growth phase, as compared with the corresponding
prepubertal activities, although this only reached
statistical significance for the mandibular sites.
Figure 1 shows the pooled maxillary and mandibular
GCF parameters in the subjects clustered according
to the growth phases, with the corresponding ES
coefficients between the growth phases. Low ES
coefficients were seen for total GCF protein, which
reached 0.6. On the contrary, the highest ES coeffi-
cients were those related to the total GCF ALP activity,
especially when considering the pubertal and prepu-
bertal growth phases, which reached 2.0. Intermediate
ES coefficients were seen for the normalized GCF ALP
Table 1. Ages of the Subjects According to Growth Phasea
CVM Stage n
Age, y
Mean 6 SD Min–Max
Prepubertal 21 10.2 6 1.3 7.8–13.0
Pubertal 18 11.4 6 1.4 8.3–13.7
Postpubertal 11 14.8 6 1.8 12.6–17.7
a CVM indicates cervical vertebral maturation; n, number of
subjects in each group; Min, minimum age; and Max, maximum age.
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activity, as between 1.3 and 1.4. However, the
variability for the pubertal growth phase of this GCF
parameter was also notably large.
DISCUSSION
The present study has initially shown that total GCF
protein content is not a reliable indicator of the different
growth phases. While confirming that total GCF ALP
activity would be a reliable biologic indicator of skeletal
maturation,10 it firstly showed that this GCF ALP
activity would have diagnostic potential when ex-
pressed as total but not normalized values.
As the quality and quantity of GCF changes during
periodontal inflammation,7 local tissue health is nec-
essary to exclude any possible unwanted bias. In the
present study, all of the enrolled subjects showed
optimal periodontal conditions. Moreover, by sampling
the GCF at the central incisors, which like the lateral
incisors, were fully erupted, the present data and
previous12 data show that neither the total GCF protein
content nor the total GCF ALP activity are influenced
by the different dentition stages. Moreover, to reduce
intersubject variability, multiple collection sites in each
of the maxilla and mandible sites were used. According
to previous evidence,10 no significant differences were
seen for these GCF parameters when comparing
maxillary and mandibular scores within each dentition
phase (recorded as intermediate and late mixed and
permanent; not shown).
A number of GCF constituents have been proposed
as diagnostic indicators of periodontal status during
periodontitis15,16 and orthodontic tooth movement.17
However, although the total GCF protein content was
initially evaluated some 40 years ago18 and has been
shown to be lower when compared to that of serum
under healthy conditions,7 no investigations have
evaluated the possibility of using this GCF parameter
as a clinical diagnostic aid in dentistry. The rationale
for using total GCF protein content derives from the
overall greater amounts in terms of the full protein
content, as compared to a single constituent, whereby
the quantification is easier and more reliable, espe-
cially when considering the setting up of a chairside kit
for routine clinical determination.
Although not using any method for precise assess-
ment of the individual growth phases, a previous study9
reported greater gingival total protein content in
growing subjects as compared with an older group.
In contrast, no differences in total GCF protein content
were seen.9 The lack of significant changes in total
GCF protein content is consistent with the hypothesis
that the amount of GCF, ie, the flow rate, is not
sensitive to the different growth phases. Therefore, the
GCF volume would also not be expected to be
influenced by the pubertal growth phase.
ALP is an enzyme that is necessary for bone
mineralization,19 with its activity shown to be correlated
with local tissue remodeling during orthodontic tooth
movement20 and periodontal inflammation.7,16 Previous
findings have shown a two-fold peak increase in total
GCF ALP activity during the pubertal growth phase10;
however, the present study initially shows that the
GCF ALP activity is more sensitive to the growth
phases when expressed as the total GCF ALP activity
rather than the normalized GCF ALP activity.
A further goal of the present study was to estimate
the diagnostic accuracy of the GCF parameters as
indicators of growth phase in individual subjects. In this
regard, a difficulty resides in intragroup variability and
the number of subjects examined, which also deter-
mines the variability of the data. A statistical approach
to quantify this ratio (taking into account the sizes of
the study populations) is provided by the calculation of
Table 2. The Different Gingival Crevicular Fluid (GCF) Parameters From the Maxillary and Mandibular Sites According to Growth Phase (n
5 50)*
Parameter Growth Phase Maxillary Sites Mandibular Sites
Total GCF proteins (mg/sample) Prepubertal 1.0 (0.6; 2.4) 1.2 (0.6; 1.7)
Pubertal 1.7 (0.8; 2.1) 1.2 (0.6; 1.5)
Postpubertal 1.0 (0.2; 1.9) 1.1 (0.5; 1.4)
Diff NS NS
Total GCF ALP activity (mU/sample) Prepubertal 48.9 (25.6; 66.9) 42.0 (34.2; 47.9)
Pubertal 73.8 (46.5; 122.7)a 78.9 (55.7; 92.1)a
Postpubertal 21.9 (12.4; 67.5)b 34.0 (14.2; 37.1)a,b
Diff P , .01 P , .001
Normalized GCF ALP activity
(mU/mg proteins)
Prepubertal 38.6 (29.9; 45.3) 34.1 (27.5; 58.3)
Pubertal 50.2 (32.5; 89.9) 69.5 (36.2; 121.6)a
Postpubertal 46.5 (19.6; 59.4) 36.0 (13.5; 66.7)
Diff NS P , .05
* Data are presented as medians (25th;75th percentiles). Diff indicates significance of the differences among the growth phases; ALP, alkaline
phosphatase. Statistically significant differences at the pairwise comparisons: a, with the corresponding prepubertal phase; b, with the
corresponding pubertal phase. NS indicates no statistically significant difference. No significant differences were seen between the maxillary and
mandibular sites within each growth phase for any GCF parameter.
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the ES coefficient,13 as has been used previously for
this purpose for different parameters.10,21,22
In the present study, the ES coefficients show that
the total GCF protein content has no clinically relevant
association with the different growth phases, while the
total GCF ALP activity shows notable changes when
comparing the prepubertal or postpubertal growth
phases with the pubertal growth phase (Figure 1). In
particular, the ES coefficients between the pubertal
and prepubertal, and the pubertal and postpubertal
growth phases are 2.0 and 1.7, respectively. There-
fore, the total GCF ALP activity has potential as a
diagnostic aid in the identification of the pubertal
growth phase in individual subjects, as has also been
reported previously.10 In the present study, a first
comparison of the diagnostic potential of the GCF
ALP, expressed as total or normalized activities, was
made, which shows that the use of the total GCF ALP
activity is preferable both for research and for future
clinical practice. Indeed, although they are above the
threshold of 1.0, the ES coefficients for the normalized
GCF ALP activities are not greater than 1.4 (Figure 1).
The notably large variability of the normalized GCF
ALP activities and especially for the pubertal growth
phase (Table 2; Figure 1C) might be responsible for
this summatory variability effect of the quantifications
of total protein content and enzyme activity. This has
major implications in the development of future
chairside kits for the identification of growth phases
in individual subjects for routine use in clinical practice.
Moreover, future research will address whether refer-
ence values for ALP activity within each growth phase
have satisfactory diagnostic performances.
CONCLUSIONS
N Total GCF protein content is not sensitive to the
growth phases.
N GCF ALP activity is a promising diagnostic tool for
identification of the growth phases in individual
subjects when expressed as the total, rather than
the normalized, values.
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